Results 181 to 190 of about 19,095 (260)

A comparison of ICD- 11 and DSM-5 criteria for PTSD among a representative sample of Chinese earthquake survivors. [PDF]

Eur J Psychotraumatol, 2020
Cao C, Wang L, Wu J, Bi Y, Yang H, Fang R, Li G, Liu P, Luo S, Hall BJ, Elhai JD.   +10 more
europepmc   +1 more source

Pharmacodynamic Activity of [¹⁸F]-Fluorthanatrace Poly(ADP-ribose) Polymerase Positron Emission Tomography in Patients With <i>BRCA1/2</i>-Mutated Breast Cancer Receiving Talazoparib. [PDF]

JCO Precis Oncol
Lin LL, Wong F, Lin R, Yap T, Litton JK.
europepmc   +1 more source

Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson. [PDF]

NPJ Precis Oncol
Lim JU, Lin HY, Kang L, Le H, Tang TY, Champiat S, Dumbrava EE, Le X, Naing A, Piha-Paul SA, Ahnert JR, Tsimberidou AM, Yap TA, Fu S, Meric-Bernstam F, Hong DS.   +15 more
europepmc   +1 more source

Barriers to publishing early phase clinical trials: the oncologists' perspective. [PDF]

Oncologist
Lucassen MJJ, Bergmann P, Husson O, Banerji U, Basu B, Melero I, Calvo E, Cassier PA, Drilon A, Fong PC, Garralda E, Joshua AM, Lin CC, Lopez J, Moreno V, Minchom A, Plummer R, Postel-Vinay S, Spreafico A, Shimizu T, Yap TA, Yap C, De Bono JS, Steeghs N.   +23 more
europepmc   +1 more source

The Inflammatory Bridge Between Type 2 Diabetes and Neurodegeneration: A Molecular Perspective. [PDF]

Int J Mol Sci
Kacem H, d'Angelo M, Qosja E, Topi S, Castelli V, Cimini A.   +5 more
europepmc   +1 more source

A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers. [PDF]

Cancer
Ahmed J, Janku F, Karp DD, Piha-Paul SA, Tsimberidou AM, Yap TA, Stephen B, Yang Y, Gurses S, Liu Q, Song J, Meric-Bernstam F, Naing A.   +12 more
europepmc   +1 more source

Loss of the DNA Repair Gene RNase H2 Identifies a Unique Subset of DDR-Deficient Leiomyosarcomas. [PDF]

Mol Cancer Ther
Nakazawa MS, Silverman IM, Rimkunas V, Veloso A, Glodzik D, Johnson A, Ohsumi TK, Patel SR, Conley AP, Roland CL, Soliman PT, Beird HC, Wu CC, Ingram DR, Lazcano R, Song D, Wani KM, Lazar AJ, Yap TA, Wang WL, Livingston JA.   +20 more
europepmc   +1 more source

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial. [PDF]

Nat Med
Yap TA, Sweis RF, Vaishampayan U, Kilari D, Gainor JF, McKean M, Barve M, Tarhini AA, Bockorny B, Sonpavde G, Park D, Babu S, Ju Y, Liu L, Henry S, Tirucherai GS, DeWall S, Qatanani M, Marantz JL, Gan L.   +19 more
europepmc   +1 more source

¿Otro terremoto?

, 1969
openaire   +2 more sources